Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 11/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 11/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24709364 | 0.80 | KISS1R (0.36) | KISS1RALDH1A1 | |
| SCHEMBL12145493 | 0.76 | SMN1; SMN2 (0.41) | MTNR1AMTNR1BKDM4EMAPK1HIF1A | |
| SCHEMBL21152766 | 0.76 | HTR2A (0.32) | — | |
| SCHEMBL18404646 | 0.76 | KMT2A (0.42) | MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL18478390 | 0.75 | MTNR1A (0.39) | MTNR1AMTNR1BKDM4EMAPK1HIF1A | |
| SCHEMBL23486852 | 0.75 | SLC6A2 (0.32) | — | |
| SCHEMBL23083771 | 0.75 | KDM4E (0.44) | MTNR1AMTNR1BKDM4EMAPK1HIF1A | |
| SCHEMBL25490411 | 0.75 | — | — | |
| SCHEMBL23083836 | 0.75 | KDM4E (0.44) | MTNR1AMTNR1BKDM4EMAPK1HIF1A | |
| SCHEMBL21276665 | 0.74 | PAOX (0.46) | KDM4EMAPK1HIF1ATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220185838-A1 | CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN | UNIV BASEL (CH) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185838-A1 | CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN | MAG, PMP22, SIGLEC7 | MTNR1A 3028/4885MTNR1B 2812/4885KDM4E 2824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.